Nasdaq to delist certain securities suspended from trading
Source: SeekingAlpha
2025-09-24 07:58:36 ET
More on Nasdaq
- Nasdaq: Fairly Valued For Steady Compounding
- Nasdaq, Inc. (NDAQ) Presents At Barclays 23rd Annual Global Financial Services Conference Transcript
- Nasdaq, Inc. 2025 Q2 - Results - Earnings Call Presentation
- SEC clears Cboe, Nasdaq, NYSE to fast-track crypto ETP listings
Read the full article on Seeking Alpha
For further details see:
Nasdaq to delist certain securities suspended from trading
Brainstorm Cell Therapeutics Inc.
NASDAQ: BCLI
BCLI Trading
-6.95% G/L:
$0.7416 Last:
22,410 Volume:
$0.79356 Open:
BCLI Latest News
June 02, 2026 09:00:00 am
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
May 28, 2026 07:45:00 am
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
BCLI Stock Data
$6,179,474
9,804,398
11.34%
6
566390%
Biotechnology & Life Sciences
Healthcare
US
New York
